1d
Medpage Today on MSNFirst-Ever Prenatal Treatment for Spinal Muscular Atrophy Shows PromiseThe first prenatal therapy for spinal muscular atrophy (SMA) showed promising results, a case report indicated. More than 2 ...
7h
News Medical on MSNPromising results from first prenatal therapy for spinal muscular atrophySpinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before birth. Scientists at St. Jude ...
Discover the first in-utero treatment for spinal muscular atrophy (SMA) using risdiplam. Promising results show no SMA signs ...
Exercise can make a significant difference for patients with SMA by working alongside other medical advancements to improve ...
The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...
Mother took Evrysdi for SMA before birth; baby later received Zolgensma. Dr. Richard Finkel at St. Jude led study showing no ...
A toddler was successfully treated for a rare genetic disease, spinal muscular atrophy, after world-first in-womb therapy.
A two-and-a-half-year-old girl shows no signs of a rare genetic disorder, after becoming the first person to be treated for ...
February 19, 2025) Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before birth. Scientists ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results